Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Old Point Financial | OPOF | Oct 14, 2024 | 19.03 | -1.14 |
Old Republic International | ORI | Oct 14, 2024 | 35.64 | +0.62 |
Old Second Bancorp | OSBC | Oct 14, 2024 | 15.57 | +0.52 |
Olema Pharmaceuticals | OLMA | Oct 14, 2024 | 11.73 | -0.09 |
Olin | OLN | Oct 14, 2024 | 47.54 | +0.27 |
Ollies Bargain Oulet | OLLI | Oct 14, 2024 | 94.65 | -1.50 |
Olo A | OLO | Oct 14, 2024 | 4.79 | +0.63 |
Olympic Steel | ZEUS | Oct 14, 2024 | 39.24 | -0.71 |
Omega Flex | OFLX | Oct 14, 2024 | 49.17 | -0.97 |
Omega Healthcare Investors | OHI | Oct 14, 2024 | 39.95 | +0.43 |
Omega Therapeutics | OMGA | Oct 14, 2024 | 0.95 | -0.88 |
Omeros | OMER | Oct 14, 2024 | 3.97 | +1.28 |
OmniAb | OABI | Oct 14, 2024 | 3.97 | -1.73 |
Omnicell | OMCL | Oct 14, 2024 | 42.73 | +0.26 |
Omnicom Group | OMC | Oct 14, 2024 | 103.26 | +0.39 |
On Holding | ONON | Oct 14, 2024 | 49.61 | -0.78 |
ON Semiconductor | ON | Oct 14, 2024 | 72.79 | +3.50 |
ON24 | ONTF | Oct 14, 2024 | 6.15 | -0.97 |
OncoCyte | OCX | Oct 14, 2024 | 3.12 | +2.30 |
Oncolytics Biotech | ONCY | Oct 14, 2024 | 1.15 | -8.00 |
Onconetix | ONCO | Oct 14, 2024 | 6.20 | +4.38 |
Oncternal Therapeutics | ONCT | Oct 14, 2024 | 1.05 | -6.25 |
Ondas Holdings | ONDS | Oct 14, 2024 | 0.98 | +8.48 |
ONE Gas | OGS | Oct 14, 2024 | 72.35 | +0.89 |
One Liberty Properties | OLP | Oct 14, 2024 | 26.87 | -0.11 |
One Stop Systems | OSS | Oct 14, 2024 | 2.59 | +9.75 |
OneConnect Financial Technology ADR | OCFT | Oct 14, 2024 | 2.47 | -18.21 |
OneMain | OMF | Oct 14, 2024 | 46.35 | +0.37 |
OneMedNet | ONMD | Oct 14, 2024 | 0.66 | +0.15 |
ONEOK | OKE | Oct 14, 2024 | 97.50 | +0.92 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.